Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pioglitazone-glimepiride vs glimepiride + pioglitazone in type 2 diabetes
CTR20140390Phase 3Active
- Sponsor
- Jiangsu Deyuan Pharmaceutical
- Start
- Mar 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of glimepiride + pioglitazone in type 2 diabetes mellitus (T2DM), sponsored by Jiangsu Deyuan Pharmaceutical. Started Mar 2015; status: active.
02
Drugs
glimepiride + pioglitazone
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on CTR20140390.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20140390.